|
BAYER HEALTHCARE LLC DR SCHOLLS FREEZE AWAY DUAL ACTION; UNIT, CRYOSURGICAL, ACCESSORIES
|
Back to Search Results |
|
| Model Number |
N/A |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Burn(s) (1757)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
This spontaneous case was reported by a consumer and describes the occurrence of medical device site burn ("she received a major burn.She stated that the burn is 7.5cm.She stated that it is very deep") in a (b)(6) female patient who received dr scholls freeze away dual action cutaneous spray for therapeutic skin care topical.The occurrence of additional non-serious events is detailed below.Medical conditions: consumer reported that there's no relevant medical history.On an unknown date, the patient started dr scholls freeze away dual action.On (b)(6) 2018, 1 day after starting dr scholls freeze away dual action, the patient experienced medical device site vesicles ("i had blisters after using this.") and medical device site scab ("it turned into a hard scab that popped.").On an unknown date, the patient experienced medical device site burn (seriousness criteria medically significant and intervention required).The patient was treated with sulfadiazine silver (silver sulfadiazine).Dr scholls freeze away dual action was withdrawn.On (b)(6) 2018, the medical device site vesicles had resolved.On (b)(6) 2018, the medical device site scab had resolved.The reporter provided no causality assessment for medical device site burn and medical device site vesicles with dr scholls freeze away dual action.The reporter considered medical device site scab to be related to dr scholls freeze away dual action.Diagnostic results (normal ranges are provided in parenthesis if available): body mass index was 21.9 kg/sqm.This (b)(6) female patient dr scholls freeze away dual action (salicylic acid, dimethyl ether, propane) for therapeutic skin care topical and 1 day after starting experienced a medical device site burn (unlisted).This case lacks information on patient's relevant medical data and details surrounding the event such as which kind of skin lesion patient had before and if patient has history of allergy skin reactions.Considering the very close temporal relationship and localization of product application, in a conservative approach, company cannot exclude causality of suspect drug to medical device site burn; thus, deemed related, in agreement with reporter.This case was regarded as incident.
|
| |
|
Additional Manufacturer Narrative
|
|
This spontaneous case was reported by a consumer and describes the occurrence of medical device site burn ("she received a major burn.She stated that the burn is 7.5cm.She stated that it is very deep") in a 52-year-old female patient who received dr scholls freeze away dual action cutaneous spray (batch no.Unk) for therapeutic skin care topical.The occurrence of additional non-serious events is detailed below.Medical conditions: consumer reported that there's no relevant medical history.On an unknown date, the patient started dr scholls freeze away dual action.On (b)(6) 2018, the patient experienced medical device site vesicles ("i had blisters after using this.") and scab ("it turned into a hard scab that popped."), 1 day after starting dr scholls freeze away dual action.On an unknown date, the patient experienced medical device site burn (seriousness criteria medically significant and intervention required).The patient was treated with sulfadiazine silver (silver sulfadiazine).Dr scholls freeze away dual action was withdrawn.On (b)(6) 2018, the medical device site vesicles had resolved.On (b)(6) 2018, the scab had resolved.At the time of the report, the medical device site burn outcome was unknown.The reporter provided no causality assessment for medical device site burn and medical device site vesicles with dr scholls freeze away dual action.The reporter considered scab to be related to dr scholls freeze away dual action.Diagnostic results (normal ranges are provided in parenthesis if available): body mass index was 21.9 kg/sqm.Quality-safety evaluation of ptc: a ptc investigation cannot be conducted by the quality unit as a batch number or sample was not provided.A quality defect was not confirmed.The reported medical events are not indicative of a quality defect per se.Most recent follow-up information incorporated above includes: on 21-mar-2019: entering quality-safety evaluation of ptc: unconfirmed quality defect; final risk category v.No lot number or device sample was received in this case.At this time, we have no information suggesting that the device failed to meet its specifications.We will conduct a review of our complaint records and other non-conformances data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
|
| |
|
Search Alerts/Recalls
|
|
|